Early Phase 1 PTSD Trial, Recruiting (NCT01327690)

Early Phase 1 PTSD Trial, Recruiting NCT01327690 Sponsor: Soul Medicine Institute Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT01327690 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to follow instructions, fill out written forms, and give informed consent to participate.
People who can read and write in English.
People who are in good physical health.
People who are currently serving in the military, are veterans, or are family members of active duty military or veterans.

Who may not be able to join:

There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Dawson Church, PhD, Soul Medicine Institute

Phone: 707 237 6951

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT01327690

Sponsor: Soul Medicine Institute

Phase: Early Phase 1

Status: Recruiting

Condition: PTSD

Trial contact: 707 237 6951

More information: https://clinicaltrials.gov/study/NCT01327690

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to follow instructions, fill out written forms, and give informed consent to participate.
People who can read and write in English.
People who are in good physical health.
People who are currently serving in the military, are veterans, or are family members of active duty military or veterans.

Who may not be able to join:

There are no listed exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Soul Medicine Institute

Registry

ClinicalTrials.gov

Start date

31 December 2010

Est. completion

31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from Baseline PTSD (posttraumatic stress disorder) Symptom Levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov